Remove Ads

Share on Facebook Share on Twitter

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Comfrey Leaf is an Effective Healer
#3
Tongue 
[size=4][b]Viral Bronchitis Treatments - a Natural Way to Relieve Chronic Chest Congestion[/b][/size][hr]
Quote:Was taking a red eye flight from LA to the East Coast and hoped to get some sleep on the plane but soon noticed an older gentleman a few seats away who was coughing and gasping for air. An oxygen tank confirmed that he probably had a chronic problem like emphysema or bronchitis.

After that, both of us were able to sleep all the way to the East Coast. It isn't only smoking tobacco that causes emphysema and bronchitis; almost anything that we inhale that's toxic can cause problems to develop in the lungs. Inhaling any burning thing including native American tobacco or marijuana can result in emphysema. Inhaling other people's smoke can be deadly. Even inhaling hot air from fires can have devastating effects. This is a dependable source of information on Emphysema Bronchitis. All that has to be done to verify its authenticity is to read it!

Dr. James Chappell is known for his work with chronic, severe and supposedly terminally-ill people. His natural cure method is described in detail on his site at ***** gave him the empty bottle and suggested that when he got home he could stock up on it at his local health food store. Then he could take two or three eyedroppers three or four times a day to help him breathe more easily. We have avoided adding flimsy points on Bronchitis, as we find that the addition of such points have no effect on Bronchitis.

[list][*]After 15 minutes of listening to him choke and gasp I realized I wouldn't be able to get any rest if I didn't help him.[*]Since I always carry a bottle of fenugreek and lobelia tincture with me, I approached him and introduced myself as a natural healing doctor.[*]I explained how small doses of lobelia and fenugreek can dilate the bronchial tubes making it easier to breathe.[*]In a stronger dose it can act as an expectorant and will help break up and get rid of the mucous that was making him cough so hard.[*]At a really strong dose it can act as an emetic and could actually cause the mucous to be vomited from the lungs.[*]We have included some fresh and interesting information on Emphysema Bronchitis.[*]In this way, you are updated on the developments of Emphysema Bronchitis.[*]Proposed that he follow me to the restroom where he could take the entire two-ounce bottle in one large dose.[*]This would immediately cause him to vomit all the mucous from his lungs and then he might feel much better and be able to get some rest.[*]He looked at me and said, "What do I have to lose?[*]I'm dying anyway.[*]Lead the way." We cannot be blamed if you find any other article resembling the matter we have written here about Emphysema Bronchitis.[*]What we have done here is our copyright material![*]We went back to the restroom where he immediately swallowed the contents of the two-ounce bottle.[*]Within minutes he vomited about a half cup of black mucous.[*]Instantly he could breathe again and the color returned to his face and lips.[*]I walked him back to his seat where, with tears in his eyes, he thanked me for helping him feel better.[*]It was our decision to write so much on Bronchitis after finding out that there is still so much to learn on Bronchitis.[/list]

The fluoroquinolones are a relatively new group of antibiotics. Fluoroquinolones were first introduced in 1986, but they are really modified quinolones, a class of antibiotics, whose accidental discovery occurred in the early 1960.

[size=large][b]Gastrointestinal Effects[/b][/size][hr]The most common adverse events experienced with fluoroquinolone administration are gastrointestinal (nausea, vomiting, diarrhea, constipation, and abdominal pain), which occur in 1 to 5% of patients. CNS effects. Headache, dizziness, and drowsiness have been reported with all fluoroquinolones. Insomnia was reported in 3-7% of patients with ofloxacin. Severe CNS effects, including seizures, have been reported in patients receiving trovafloxacin. Seizures may develop within 3 to 4 days of therapy but resolve with drug discontinuation. Although seizures are infrequent, fluoroquinolones should be avoided in patients with a history of convulsion, cerebral trauma, or anoxia. No seizures have been reported with levofloxacin, moxifloxacin, gatifloxacin, and gemifloxacin. With the older non-fluorinated quinolones neurotoxic symptoms such as dizziness occurred in about 50% of the patients. Phototoxicity. Exposure to ultraviolet A rays from direct or indirect sunlight should be avoided during treatment and several days (5 days with sparfloxacin) after the use of the drug. The degree of phototoxic potential of fluoroquinolones is as follows: lomefloxacin > sparfloxacin > ciprofloxacin > norfloxacin = ofloxacin = levofloxacin = gatifloxacin = moxifloxacin. Musculoskeletal effects. Concern about the development of musculoskeletal effects, evident in animal studies, has led to the contraindication of fluoroquinolones for routine use in children and in women who are pregnant or lactating. Tendon damage (tendinitis and tendon rupture). Although fluoroquinolone-asia possess caused indoor humidifier "breathe" revolution within one week of discontinuation of therapy, spontaneous ruptures have been reported as long as nine months after cessation of fluoroquinolone use. Potential risk factors for tendinopathy include age >50 years, male gender, and concomitant use of corticosteroids. Hepatoxicity. Trovafloxacin use has been associated with rare liver damage, which prompted the withdrawal of the oral preparations from the U.S. market. However, the IV preparation is still available for treatment of infections so serious that the benefits outweigh the risks. Cardiovascular effects. The newer quinolones have been found to produce additional toxicities to the heart that were not found with the older compounds. Evidence suggests that sparfloxacin and grepafloxacin may have the most cardiotoxic potential. Hypoglycemia/Hyperglycemia. Recently, rare cases of hypoglycemia have been reported with gatifloxacin and ciprofloxacin in patients also receiving oral diabetic medications, primarily sulfonylureas. Although hypoglycemia has been reported with other fluoroquinolones (levofloxacin and moxifloxacin), the effects have been mild. Hypersensitivity. Hypersensitivity reactions occur only occasionally during quinolone therapy and are generally mild to moderate in severity, and usually resolve after treatment is stopped. As the information we produce in our writing on Plastic bronchitis emedicine be utilized by the reader for informative purposes, it is very important that the information we provide be true. We have indeed maintained this.

Fluoroquinolones are approved for use only in people older than 18. They can affect the growth of bones, teeth, and cartilage in a child or fetus. The FDA has assigned fluoroquinolones to pregnancy risk category C, indicating that these drugs have the potential to cause teratogenic or embryocidal effects. Giving fluoroquinolones during pregnancy is not recommended unless the benefits justify the potential risks to the fetus. These agents are also excreted in breast milk and should be avoided during breast-feeding if at all possible. Time and tide waits for no man. So once we got an idea for writing on Bronchitis, we decided not to waste time, but to get down to writing about it immediately!

[b]Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days. [/b]

Conditions treated with Fluoroquinolones: indications and uses The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. The serum elimination half-life of the fluoroquinolones range from 3 -20 hours, allowing for once or twice daily dosing. Isn't it amazing how much information can be transferred through a single page? So much stands to gain, and to lose about Bronchitis through a single page.

[size=large][b]Classification of Fluoroquinolones[/b][/size][hr]As a group, the fluoroquinolones have excellent in vitro activity against a wide range of both gram-positive and gram-negative bacteria. The newest fluoroquinolones have enhanced activity against gram-positive bacteria with only a minimal decrease in activity against gram-negative bacteria. Their expanded gram-positive activity is especially important because it includes significant activity against Streptococcus pneumoniae. It is rather inviting to go on writing on Chronic Bronchitis. however as there is a limitation to the number of words to be written, we have confined ourselves to this. However, do enjoy yourself reading it.

[size=large][b]Third Generation[/b][/size][hr]The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species. Interesting is what we had aimed to make this article on Bronchitis. It is up to you to decide if we have succeeded in our mission!

[size=large][b]Side Effects[/b][/size][hr]The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects. Writing is something that has to be done when one is in the mood to write. So when we got in the mood to write about Chronic Bronchitis, nothing could stop us from writing!

The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. Ignorance is bliss, is it? Isn't it better to learn more than not to know about something like Bronchitis. So we have produced this article so that you can learn more about it!

All of the fluoroquinolones are effective in treating urinary tract infections caused by susceptible organisms. They are the first-line treatment of acute uncomplicated cystitis in patients who cannot tolerate sulfonamides or TMP, who live in geographic areas with known resistance > 10% to 20% to TMP-SMX, or who have risk factors for such resistance. To err is human, to forgive is divine. So we would indeed deem you to be divine if you forgive us for any misunderstandings that may arise in this article on Bronchitis. :o.


[size=medium][b]Amazing Medicinal Uses of Vicks Vaporub! - Health and Natural Medicine[/b][/size]
[Image: https://s3-us-west-2.amazonaws.com/979/imgs/aaaaa3.jpeg]

Second-generation agents include ciprofloxacin, enoxacin, lomefloxacin, norfloxacin and ofloxacin. Ciprofloxacin is the most potent fluoroquinolone against P. aeruginosa. Ciprofloxacin and ofloxacin are the most widely used second-generation quinolones because of their availability in oral and intravenous formulations and their broad set of FDA-labeled indications. A rolling stone gathers no moss. So if I just go on writing, and you don't understand, then it is of no use of me writing about Bronchitis! Whatever written should be understandable by the reader.

[size=large][b]Fluoroquinolones Advantages:[/b][/size][hr]Ease of administration Daily or twice daily dosing Excellent oral absorption Excellent tissue penetration Prolonged half-lives Significant entry into phagocytic cells Efficacy Overall safety We have used a mixture of seriousness and jokes in this composition on Bronchitis. This is to liven the mood when reading about Bronchitis.

Urinary tract infections (norfloxacin, lomefloxacin, enoxacin, ofloxacin, ciprofloxacin, levofloxacin, gatifloxacin, trovafloxacin) Lower respiratory tract infections (lomefloxacin, ofloxacin, ciprofloxacin, trovafloxacin) Skin and skin-structure infections (ofloxacin, ciprofloxacin, levofloxacin, trovafloxacin) Urethral and cervical gonococcal infections (norfloxacin, enoxacin, ofloxacin, ciprofloxacin, gatifloxacin, trovafloxacin) Prostatitis (norfloxacin, ofloxacin, trovafloxacin) Acute sinusitis (ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin (Avelox), trovafloxacin) Acute exacerbations of chronic bronchitis (levofloxacin, sparfloxacin (Zagam), gatifloxacin, moxifloxacin, trovafloxacin) Community-acquired pneumonia (levofloxacin, sparfloxacin, gatifloxacin, moxifloxacin, trovafloxacin) It is with much interest that we got about to write on Bronchitis. So we do hope that you too read this article with the same, if not more interest!

Because of their expanded antimicrobial spectrum, third-generation fluoroquinolones are useful in the treatment of community-acquired pneumonia, acute sinusitis and acute exacerbations of chronic bronchitis, which are their primary FDA-labeled indications. The third-generation fluoroquinolones include levofloxacin, gatifloxacin, moxifloxacin and sparfloxacin. We were actually wondering how to get about to writing about Chronic Bronchitis. However once we started writing, the words just seemed to flow continuously!

The fluoroquinolones are a family of synthetic, broad-spectrum antibacterial agents with bactericidal activity. The parent of the group is nalidixic acid, discovered in 1962 by Lescher and colleagues. The first fluoroquinolones were widely used because they were the only orally administered agents available for the treatment of serious infections caused by gram-negative organisms, including Pseudomonas species. Keeping to the point is very important when writing. So we have to stuck to Chronic Bronchitis, and have not wandered much from it to enhance understanding. :o.

[size=large][b]Fluoroquinolones Disadvantages:[/b][/size][hr]Tendonitis or tendon rupture Multiple drug interactions Not used in children Newer quinolones produce additional toxicities to the heart that were not found with the older agents Do not judge a book by its cover; so don't just scan through this matter on Chronic Bronchitis. read it thoroughly to judge its value and importance. :o.

[size=large][b]Fourth Generation[/b][/size][hr]The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan). It is rather interesting to note that people like reading about Chronic Bronchitis if they are presented in an easy and clear way. The presentation of an article too is important for one to entice people to read it!

[size=large][b]First Generation[/b][/size][hr]The first-generation agents include cinoxacin and nalidixic acid, which are the oldest and least often used quinolones. These drugs had poor systemic distribution and limited activity and were used primarily for gram-negative urinary tract infections. Cinoxacin and nalidixic acid require more frequent dosing than the newer quinolones, and they are more susceptible to the development of bacterial resistance. It is always better to use simple English when writing descriptive articles, like this one on Chronic Bronchitis. It is the layman who may read such articles, and if he can't understand it, what is the point of writing it?
Reply


Messages In This Thread
RE: Comfrey Leaf is an Effective Healer - by fabianmcgee - 08-06-201612:50 PM

Forum Jump:


Users browsing this thread: